Search

everythinglearnresearchcommunity

for

Search:↓

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

The document concludes that products like PRP and PRF show promise for tissue healing, but evidence of their effectiveness is inconsistent.

Platelet Rich Plasma (PRP) shows promise for tissue repair and immune response, but more research is needed to fully understand it and optimize its use.

Low-Level Laser Therapy and other light treatments for hair growth lack strong evidence and need more research.

This therapy effectively treats resistant alopecia areata with minimal side effects.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Bacteria in our hair can affect its health and growth, and studying these bacteria could help us understand hair diseases better.

The mtDNA N haplogroup is linked to a higher risk of late-onset lupus and specific symptoms in Han Chinese women.

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Some plant-based chemicals may help with hair growth, but more research is needed to confirm their effectiveness.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

Burn scars heal abnormally and more research is needed to find better treatments.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Finasteride causes reduced tear flow and severe eye inflammation.

Skin abnormalities can indicate immunodeficiency due to shared origins with the immune system.